← The Wire
FEIMNasdaq
FREQUENCY ELECTRONICS INC
Instruments For Meas & Testing of Electricity & Elec Signals · DE · CIK 39020
Designs and manufactures precision time and frequency generation systems for satellites and C4ISR/EW applications
$741M
Market cap
$61.77
Last close
-1.2%
1D
-11.4%
5D
289K
Volume
Price · last 39 sessions+16.7%
May 4L $52.94 · H $77.15Jun 29
375
Total filings
Jun 12, 2026
Last filing
04/30
Fiscal year end
8-KMaterial Agreement · New Debt / ObligationJun 12, 202610-QFORM 10-QMar 17, 20268-KResults of OperationsMar 11, 202610-QFORM 10-QDec 15, 20258-KResults of OperationsDec 11, 20258-KShareholder VoteOct 9, 202510-QFORM 10-QSep 15, 20258-KResults of Operations · Company UpdateSep 11, 2025DEF 14AFORM DEF 14AAug 28, 202510-KFORM 10-KJul 18, 20258-KResults of OperationsJul 10, 202510-QFORM 10-QMar 17, 20258-KResults of OperationsMar 13, 202510-QFORM 10-QDec 16, 20248-KResults of OperationsDec 10, 20248-KExecutive Change · Reg FD DisclosureDec 5, 20248-KExecutive Change · Shareholder VoteOct 9, 202410-QFORM 10-QSep 13, 2024DEF 14AFORM DEF 14AAug 28, 202410-KFORM 10-KAug 2, 20248-KResults of Operations · Company UpdateJul 22, 202410-QFORM 10-QMar 18, 20248-KResults of OperationsMar 14, 202410-QFORM 10-QDec 15, 20238-KResults of OperationsDec 12, 20238-KShareholder VoteOct 10, 202310-QFORM 10-QSep 14, 20238-KResults of OperationsSep 14, 2023DEF 14AFORM DEF 14AAug 28, 20238-KAuditor ChangeAug 1, 202310-KFORM 10-KJul 27, 20238-KResults of OperationsJul 13, 202310-QFORM 10-QMar 17, 20238-KResults of OperationsMar 9, 2023SC 13GSC 13GFeb 7, 20238-KExecutive Change · Reg FD DisclosureJan 17, 202310-K/AFORM 10-K/ADec 21, 202210-QFORM 10-QDec 20, 20228-KResults of Operations · Company UpdateDec 20, 20228-KRestatement · Results of OperationsDec 16, 20228-KShareholder VoteOct 7, 202210-QFORM 10-QSep 14, 20228-KResults of OperationsSep 13, 2022DEF 14AFORM DEF 14AAug 30, 202210-KFORM 10-KJul 14, 20228-KExecutive Change · Results of OperationsJul 13, 202210-QFORM 10-QMar 15, 20228-KResults of OperationsMar 10, 202210-QFORM 10-QDec 14, 20218-KResults of OperationsDec 9, 20218-KShareholder VoteOct 7, 202110-QFORM 10-QSep 14, 20218-KResults of OperationsSep 13, 2021DEF 14AFORM DEF 14AAug 30, 20218-KMaterial AgreementAug 27, 2021SC 13GSC 13GJul 7, 202110-KFORM 10-KJun 30, 20218-KResults of OperationsJun 29, 202110-QFORM 10-QMar 12, 20218-KResults of OperationsMar 11, 202110-QFORM 10-QDec 11, 20208-KResults of OperationsDec 10, 20208-KShareholder VoteOct 9, 202010-QFORM 10-QSep 14, 20208-KExecutive Change · Reg FD DisclosureSep 14, 20208-KResults of OperationsSep 10, 2020DEF 14AFORM DEF 14AAug 28, 20208-KExecutive Change · Reg FD DisclosureAug 28, 202010-KFORM 10-KJul 29, 20208-KResults of OperationsJul 16, 20208-KBylaw AmendmentJun 25, 20208-KCode of Ethics · Company UpdateMay 7, 20208-KMaterial Agreement · New Debt / ObligationApr 16, 202010-QFORM 10-QMar 16, 20208-KResults of OperationsMar 12, 20208-KBylaw AmendmentFeb 13, 20208-KCompany UpdateJan 31, 20208-KExecutive ChangeJan 27, 202010-QFORM 10-QDec 16, 20198-KResults of OperationsDec 12, 2019
What Changed
Risk factors · Aug 2, 2024 → Jul 18, 20258 added · 13 removed between the two most recent 10-Ks. The risks a company starts — or stops — disclosing are often the story.
Newly disclosed
- During fiscal year 2025, only Northrop Grumman accounted for more than 10% of the Company’s consolidated revenues; however, the Company has other large customers that it relies on for significant portions of its consolidated revenues.
- The Company has identified a material weakness in its internal control over financial reporting for the fiscal year ended April 30, 2024.
- While we would expect to compete and be well positioned as the incumbent on existing programs, we may not be successful and, even if we are successful, the replacement programs may be funded at lower levels, which could adversely affect our business, financial position, results of operations and/or cash flows.
- We may identify additional material weaknesses in the future or otherwise fail to maintain an effective system of internal controls, which may result in material misstatements of our financial statements or cause us to fail to meet our reporting obligations.
- As of April 30, 2025, the Company’s management believes the identified material weakness have been remediated.
- This could result in adverse consequences to our financial position, results of operations and/or cash flows.
- Risks Related to Our Common Stock Our stock price may continue to be volatile.
- We use estimates when accounting for contracts.
No longer disclosed
- We determined that we did not maintain adequate controls over to the review of the calculation of the loss provision, which the Company concluded constituted a material weakness in the Company’s internal control over financial reporting as of April 30, 2024.
- The Company believes by April 30, 2025, the Company’s next annual reporting date, is sufficient time to remediate the material weakness fully or, if not fully remediated, to complete testing of the remediated controls.
- During fiscal year 2024, Lockheed Martin, Northrop Grumman, Office of Naval Research and BAE Systems each accounted for more than 10% of the Company’s consolidated revenues.
- For fiscal 2024 and fiscal 2023, approximately 98% and 95% of the Company’s sales, respectively, were made under contracts to the U.S.
- Although our shares of common stock are listed on the Nasdaq Global Market, we have historically experienced a relatively low trading volume of approximately 18,000 shares per trading day.
- Although the Company ’ s failure to establish and maintain effective internal control over financial reporting has not resulted in a material misstatement of the Company ’ s prior annual or interim consolidated financial statements, such failure could result in material misstatements in future consolidated financial statements.
- Additionally, the Company ’ s failure to establish and maintain effective internal control over financial reporting could result in the Company ’ s failure to meet its reporting and financial obligations, which in turn could have a negative impact on its financial condition.
- Due to the relatively low trading volume of our shares of common stock, the sale of a large number of shares of our outstanding common stock may significantly depress the price of our common stock. 15 Table of Contents
- This could result in adverse consequences to our financial position, results of operations and/or cash flows. 14 Table of Contents Risks Related to Our Common Stock Our stock price may continue to be volatile.
- While we would expect to compete and be well positioned as the incumbent on existing programs, we may not be successful and, even if we are successful, the replacement programs may be funded at lower levels.
- If our low trading volume continues, holders of shares of our common stock may have difficulty selling shares of our common stock in the manner, at the time, or at a price they desire.
- The relatively low trading volume of our common stock may limit your ability to sell your shares.
Similar companies
Comparable business profile · signals at a glance